Shopify Inc. vs Sanofi SA — how do they compare? Shopify Inc. trades at $122.8 (market cap $161.53B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Shopify Inc. is the larger of the two by market cap, and Sanofi SA pays a 5.5% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals.
| SHOP | SNY | |
|---|---|---|
Market Cap | $161.53B | $104.83B |
Sector | Technology | Health |
52-Week High | $179.01 | $52.34 |
52-Week Low | $95.40 | $41.33 |
Enterprise Value | $155.97B | $121.32B |
Dividend Yield | — | 5.5% |
Trailing returns across standard periods
Latest headlines on both assets
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →